03737 ZHONGZHIPHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.39X | Oper Margin | 7.0% |
|---|---|---|---|
| LT Debt/Equity | 9.6% | Net Margin | 4.3% |
| Total Debt/Equity | 16.9% | Return on Equity | 8.5% |
| Price/Book | 0.59X | Return on Assets | 4.8% |
| (HKD 0.810) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 101.26 | 179.41 | 119.28 | 63.76 | 164.41 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -43.6 | +50.4 | +87.1 | -61.2 | +28.2 |
| Earnings Per Share (HKD) | 0.12 | 0.212 | 0.141 | 0.076 | 0.198 |
| Earnings Per Share Growth (%) | -43.4 | +50.4 | +84.8 | -61.6 | +28.9 |
| Dividend Per Share (HKD) | 0.050 | 0.090 | 0.090 | No dividend | 0.052 |
| P/E* (X) | 6.76 | 3.82 | 5.75 | 10.63 | 4.08 |
| Yield (%) | 6.17 | 11.11 | 11.11 | N/A | 6.36 |
| Dividend Share (%) | 41.74 | 42.49 | 63.92 | N/A | 25.96 |
| Book NAV (HKD) | 1.375 | 1.338 | 1.302 | 1.273 | 1.159 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 2,215 | 2,050 | +8.0 | 1,826 |
| Operating Result | 146.349 | 207.15 | -29.4 | 129.957 |
| Profit Before Taxation | 146.897 | 207.581 | -29.2 | 130.651 |
| Taxation | 50.75 | 43.447 | +16.8 | 23.736 |
| Profit /( Loss) After Taxation | 96.147 | 164.134 | -41.4 | 106.915 |
| Minority Interests | 0.935 | 1.359 | -31.2 | 0.528 |
| Net Profit | 95.212 | 162.775 | -41.5 | 106.387 |
| Earnings Per Share () | 0.1198 | 0.2118 | -43.4 | 0.1408 |
| Dividend Per Share () | 0.0500 | 0.0900 | -44.4 | 0.0900 |
| Announcement Date | 2025-03-26 | 2024-03-22 | NA | 2023-03-22 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
